Latest .bd Stories

FRANKLIN LAKES, N.J., May 21, 2013 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 49.5 cents per common share, payable on June 28, 2013 to holders of record on June 7, 2013. The indicated annual dividend rate is $1.98 per share. About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is...

SPARKS, Md., April 27, 2013 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today an international distributor agreement with Bruker Daltonics Inc. to sell and provide front-line technical support for the co-labeled BD(TM) Bruker MALDI Biotyper(TM) System. Microbial identification and antimicrobial susceptibility testing is the end-point of the majority of work a microbiology lab performs on a daily basis and is very time consuming. The...

New Safety Device Designed to Support the Needs of Biologics FRANKLIN LAKES, N.J., April 11, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the commercial launch of a new passive needle guard technology, BD UltraSafe PLUS(TM). The BD UltraSafe PLUS(TM) Passive Needle Guard has received 510(k) clearance as an anti-needlestick safety device. This product, in addition to offering...

BD MAX(TM) Cdiff Assay Receives FDA Clearance BALTIMORE, April 9, 2013 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it received FDA clearance to market the BD MAX(TM) Cdiff Assay in the United States. The assay is performed on the fully-automated BD MAX(TM) System and is designed to rapidly and accurately detect the toxin B gene (tcdB), which has been shown to be essential to...

FRANKLIN LAKES, N.J., April 8, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2013 earnings conference call on Thursday, May 2, 2013, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning. The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be...

Leading Canadian Laboratory Services Provider to Implement BD Kiestra(TM) Total Laboratory Automation Platform by Third Quarter 2013 MISSISSAUGA, Ontario, April 8, 2013 /PRNewswire/ -- CML HealthCare Inc. (TSX: CLC) (the "Company" or "CML"), a leading community-based provider of laboratory and medical imaging services in Ontario and British Columbia, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement for CML...

First drug approved for launch in BD Simplist(TM) family of products FRANKLIN LAKES, N.J., March 27, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the first drug to be offered in the just-launched BD Simplist(TM) ready-to-administer, line of prefilled generic injectables. BD Simplist prefilled injectables will be commercialized and...

FRANKLIN LAKES, N.J., Feb. 28, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in March 2013: Cowen and Company 33(rd) Annual Healthcare ConferenceMarch 4, 20131:30 p.m. ET Raymond James 34(th) Annual Institutional Investors ConferenceMarch 5, 20132:50 p.m. ET Barclays Global Healthcare ConferenceMarch 13, 201310:45 a.m. ET Live...

FRANKLIN LAKES, N.J., Feb. 7, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2013: Leerink Swann Global Healthcare Conference 2013February 14, 20132:00 p.m. ET 2013 Citi Global Healthcare ConferenceFebruary 26, 20138:00 a.m. ET 2013 RBC Capital Markets' Healthcare ConferenceFebruary 27, 201311:30 a.m. ET Live webcasts...

FRANKLIN LAKES, N.J., Jan. 29, 2013 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 49.5 cents per common share, payable on March 29, 2013 to holders of record on March 8, 2013. The indicated annual dividend rate is $1.98 per share. About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to...